Literature DB >> 15995025

The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study.

William V Good1, Robert J Hardy, Velma Dobson, Earl A Palmer, Dale L Phelps, Michelle Quintos, Betty Tung.   

Abstract

OBJECTIVES: To estimate the incidence of retinopathy of prematurity (ROP) in the Early Treatment for Retinopathy of Prematurity (ETROP) Study and compare these results with those reported in the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Study.
METHODS: The ETROP Study, as part of its protocol, screened 6998 infants at 26 centers throughout the United States. Serial eye examinations were conducted for infants born weighing <1251 g, making it possible to estimate the frequency of ROP in different birth weight and gestational age categories. ROP was categorized according to the International Classification for ROP.
RESULTS: The incidence of any ROP was 68% among infants of <1251 g. The findings were compared with those for infants born in 1986 and 1987 in the CRYO-ROP Study. The overall incidences of ROP were similar in the 2 studies, but there was more zone I ROP in the ETROP Study. Among infants with ROP, more-severe ROP (prethreshold) occurred for 36.9% of infants in the ETROP Study and 27.1% of infants in the CRYO-ROP Study. The gestational age of onset of ROP of different severities has changed very little since the CRYO-ROP Study was conducted.
CONCLUSIONS: ROP remains a common important problem among infants with birth weights of <1251 g. The incidence of ROP, time of onset, rate of progression, and time of onset of prethreshold disease have changed little since the CRYO-ROP natural-history study.

Entities:  

Mesh:

Year:  2005        PMID: 15995025     DOI: 10.1542/peds.2004-1413

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  121 in total

1.  Retinopathy of prematurity.

Authors:  W V Good; S M Carden
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

2.  Evaluation of vascular disease progression in retinopathy of prematurity using static and dynamic retinal images.

Authors:  Jane S Myung; Rony Gelman; Grant D Aaker; Nathan M Radcliffe; R V Paul Chan; Michael F Chiang
Journal:  Am J Ophthalmol       Date:  2011-10-22       Impact factor: 5.258

3.  Serum fructosamine and retinopathy of prematurity.

Authors:  Senol Bozdag; Serife Suna Oguz; Tulin Gokmen; Zuhal Tunay; Levent Tok; Nurdan Uras; Omer Erdeve; Ugur Dilmen
Journal:  Indian J Pediatr       Date:  2011-07-06       Impact factor: 1.967

4.  Placenta microbiology and histology and the risk for severe retinopathy of prematurity.

Authors:  Minghua L Chen; Elizabeth N Allred; Jonathan L Hecht; Andrew Onderdonk; Deborah VanderVeen; David K Wallace; Alan Leviton; Olaf Dammann
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

5.  Computer-aided diagnosis of retinopathy in retinal fundus images of preterm infants via quantification of vascular tortuosity.

Authors:  Faraz Oloumi; Rangaraj M Rangayyan; Anna L Ells
Journal:  J Med Imaging (Bellingham)       Date:  2016-12-15

6.  Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.

Authors:  Melissa Liebowitz; Ronald I Clyman
Journal:  J Pediatr       Date:  2017-04-07       Impact factor: 4.406

7.  Importance of birth weight as a risk factor for severe retinopathy of prematurity when gestational age is 30 or more weeks.

Authors:  Leslie M Pierce; Edward L Raab; Ian R Holzman; Robin N Ginsburg; Scott E Brodie; Annemarie Stroustrup
Journal:  Am J Ophthalmol       Date:  2014-02-26       Impact factor: 5.258

8.  A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity.

Authors:  Kenneth W Wright; David Sami; Lisa Thompson; Rangasamy Ramanathan; Roy Joseph; Sonal Farzavandi
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  Results of screening for retinopathy of prematurity in a large nursery in Kuwait: Incidence and risk factors.

Authors:  Vivek B Wani; Niranjan Kumar; Khalid Sabti; Seemant Raizada; Nabeel Rashwan; Mumtaz M Shukkur; Mohammed Harbi
Journal:  Indian J Ophthalmol       Date:  2010 May-Jun       Impact factor: 1.848

10.  Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.

Authors:  Luca Filippi; Giacomo Cavallaro; Patrizio Fiorini; Marta Daniotti; Valentina Benedetti; Gloria Cristofori; Gabriella Araimo; Luca Ramenghi; Agostino La Torre; Pina Fortunato; Liliana Pollazzi; Giancarlo la Marca; Sabrina Malvagia; Paola Bagnoli; Chiara Ristori; Massimo Dal Monte; Anna Rita Bilia; Benedetta Isacchi; Sandra Furlanetto; Francesca Tinelli; Giovanni Cioni; Gianpaolo Donzelli; Silvia Osnaghi; Fabio Mosca
Journal:  BMC Pediatr       Date:  2010-11-18       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.